ApprovalTrail

Approval · Notice of Compliance 33504 · 2024

ACH-PROGESTERONE: Notice of Compliance 33504

Issued June 25, 2024

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
33504
Date
June 25, 2024
Company
Accord Healthcare IncKirkland, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Canadian reference product
PROMETRIUM (Organon Canada Inc.)

Products in this notice

BrandDINStatus today
ACH-PROGESTERONE02549158Marketed

Medicinal ingredients